You are here: All Products  > Roche Agrees to Nearly $3 Billion Package for ex-US Rights to Sarepta Gene Therapy; China a Major Target

Roche Agrees to Nearly $3 Billion Package for ex-US Rights to Sarepta Gene Therapy; China a Major Target

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.